4 Stocks That Have Most Impacted Market Today ( VRNG, ARQL, CUR, MFRM )

Los Angelas, CA -- (SBWIRE) -- 10/05/2012 -- Vringo, Inc. Comm (AMEX:VRNG) is very active today and traded between $4.32 - 5.55 with total traded volume of 35206688 shares. At a current price of 5.25, VRNG is +0.95 - +22.09% from the previous close of $4.30. Moreover, At Current Market Price, VRNG is in distance of +54.19% from its 50-day Moving Average price of $3.4049 and +55.42% from its 200-day Moving Average price of $3.3779. Vringo Inc (NYSEAMEX: VRNG) surged up 14.19% to $4.92 on a traded volume of 8.22 million shares. The stock is up after a federal judge removed one of the last hurdles that could have stopped the Company from going to trial October16. Vringo filed a patent suit against Google Inc and others. The judge threw out the defendants’ motion for summary judgment, which could have prevented a trial.

Can't Take A Decission Buy Or Sell : Get A Free Copy

ArQule, Inc. (NGM:ARQL) is +0.505 - +22.05% from the previous close of $2.29. It traded between $2.29 - 2.84 with total traded volume of 5596945 shares. Keep a close eye on ARQL, as the stock has been showing unusual moves over the past weeks. At Current market price, ARQL has recovered +41.16% from its 52-week Low of 1.98 and has Pulled back -66.41% from its 52-week high of 8.32. million. ArQule, Inc. (NASDAQ:ARQL): ArQule, Inc. (NASDAQ:ARQL), a maker of experimental cancer drugs, plunged US$2.81 (or -56.31%) to US$2.18 after it halted a study of a lung-tumor treatment that failed to meet goals for improving survival rates. Abnormal trading volume of ArQule was found reaching 27.24 million shares, 45 times heavier than usual day trading. The stock made a new 52-week low of US$1.98 earlier in the session. Its price, as of the latest close, was up 10% compared with the 52-week low and was 282% below the 52-week high. ArQule's market capitalization after the recent close was US$135.77 million. Since ArQule insiders such as CEOs, CFOs and Directors have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for ARQL here.

Can't Take A Decission Buy Or Sell : Get A Free Copy

Neuralstem, Inc. (AMEX:CUR) reported EPS of -0.209. For the Current Fiscal year, the company is expected to report EPS of -0.20. For the Next Quarter and Next Year, the company is expected to report EPS of -0.05 and -0.21 respectively. At Current Market Price, CURis in distance of +41.77% from its 50-day Moving Average price of $0.9029 and +35.69% from its 200-day Moving Average price of $0.9434. Neuralstem announced Thursday it will provide an update of the Phase I trial to test Neuralstem's human spinal cord stem cells, NSI-566, in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the American Neurological Association annual meeting on Monday, October 8th. The company also said it was granted approval to commence a clinical trial, through its subsidiary, Neuralstem China, to treat motor deficits due to ischemic strokes with its spinal cord stem cells NSI-566 at BaYi Brain Hospital, in Beijing, China. The approved trial will include a combined phase I/II design and will witness direct injections of NSI-566 cells into the brain. The trial is expected to begin early next year.

Can CUR Continue to Move Higher? Find Out Here

Mattress Firm Hol (NasdaqNM:MFRM) is very active today and traded between $30.66 - 33.15 with total traded volume of 3621383 shares. At a current price of 32.7622, MFRM is +2.5822 - +8.56% from the previous close of $30.18. Moreover, At Current Market Price, MFRM is in distance of +6.45% from its 50-day Moving Average price of $30.7774 and -0.84% from its 200-day Moving Average price of $33.0412. Mattress Firm Holding Corp(NASDAQ:MFRM) stock gained 6.53% to $32.15 after the company announced that the pricing of the public offering by certain of its stockholders (the Selling Stockholders) of 4,726,682 shares of the Company’s common stock. The shares of common stock will be sold at a public offering price of $29.85 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 709,002 shares of common stock on the same terms and conditions. The offering is expected to close on October 10, 2012.

Should Investors Buy MFRM Now? Get A Free Trend Analysis Here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com